Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort

Figure 2

Disease activity over time following treatment with new therapeutic agents or nontreatment. Disease activity, as measured by the disease activity score from 28-joint count with three parameters (DAS28-3), over time in patients treated or not treated with new therapeutic agents, 2000 to 2004. LEF, leflunomide.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us